Home Life Sciences Three Cases of Extranodal Rosai-Dorfman Disease and Literature Review
Article Open Access

Three Cases of Extranodal Rosai-Dorfman Disease and Literature Review

  • , and EMAIL logo
Published/Copyright: August 21, 2018

Abstract

Object

To summarize the etiology, pathology, diagnosis, clinical features, and treatment of the rare extranodal Rosai-Dorfman disease (RDD).

Methods

Clinical data of three cases of extranodal RDD who were admitted to the E. N. T. Department of the second hospital of Jilin University were analyzed retrospectively, and the literature was reviewed.

Results

Three cases of extranodal RDD (maxillary sinus, nasal pharyngeal focus, and external auditory meatus) had a low fever and weight loss rather than painless enlarged lymph nodes. Surgical intervention was managed to clarify the diagnosis. All pathological diagnoses were extranodal RDD. Predisone for oral use was given to all patients postoperatively. There was no recurrence in the following 3 months, except case 1 was lost 2 months later.

Conclusions

RDD is a rare idiopathic histiocytic proliferative disorder defined by its unique histopathological features: a proliferation of huge histiocytic cells with emperipolesis and S-100(+), CD1a(-). RDD is characterized clinically by bilateral cervical painless enlarged lymph nodes, while extranodal RDD is rarer and its manifestations varied. A defined therapeutic regimen has not been elucidated. RDD in about 20% of patients is self-limited. Surgical intervention is the main management of treatment, with glucocorticoids used in initial medical therapy. More clinical trials are necessary before drawing conclusions.

1 Introduction

Rosai-Dorfman Disease (RDD), also called sinus histiocytosis with massive lymphadenopathy, is a rare idiopathic histiocytic proliferative disorder. There are very few clinical cases of extranodal RDD. Therefore, in this study, our aim was to describe 3 cases of extranodal RDD enrolled in the E. N. T. Department of the second hospital of Jilin University from Sep. 2011 to Jun. 2014. We also present a concise overview of the clinical data and effects of therapy. We summarize the etiology, clinical features, pathology, diagnosis, differential diagnosis, treatments, and outcomes of RDD in order to improve the knowledge of RDD for otolaryngologists.

2 Case History

2.1 Case 1

A 47 year-old man was admitted to the hospital with the chief complaint of left nasal obstruction with left ipsilateral cheek swelling. Special examination demonstrated within the nasal mucosa of the bilateral nasal bottom and lateral wall of left nasal cavity edema and swelling with smooth surface. The left nasal cavity was significantly more narrow than the right one. CT scan of the nasal sinus is shown in Figure 1. Under general anesthesia, the mass of the left maxillary sinus was removed as much as possible with the use of a nasal endoscope. Histopathology report confirmed abundant large histiocytes with emperipolesis, and immunohistochemical diagnostic criteria was cytoplasmic positivity of histiocytes for S-100 protein.

Figure 1 CT scan of case 1 shows the soft tissue density image in the left maxillary sinus, left nasal bottom, and the right nasal bottom near the nasal septum and the evaded and damaged maxillary bone (black arrow).
Figure 1

CT scan of case 1 shows the soft tissue density image in the left maxillary sinus, left nasal bottom, and the right nasal bottom near the nasal septum and the evaded and damaged maxillary bone (black arrow).

2.2 Case 2

A 45 year-old man presented with left headache, ipsilateral ophthalmalgia, and ipsilateral conductive hearing loss for 1 month. Auxiliary examination demonstrated secretory otitis media (the tympanic membrane was dull and fluid level was detected). Nasopharyngoscope revealed the submucosal neoplasm extended from the fossa of Rosenmuller on the left side to the left torus, and the Eustachian tube was patent. A solid lesion measuring 38*17mm, originating from the nasopharynx, was observed in the MR images (Figure 2). Biopsy was obtained from the nasopharyngeal deep lesion under general anesthesia. We made a precise diagnosis of extranodal RDD according to the histopathology report (Figure 3).

Figure 2 MR of case 2 shows isointensity on both T1-weighted image and T2-weighted image and homogeneous enhancement after contrast administration (black arrow).
Figure 2

MR of case 2 shows isointensity on both T1-weighted image and T2-weighted image and homogeneous enhancement after contrast administration (black arrow).

Figure 3A Histopathology report of case 2 shows a proliferation of histiocytes (arrow) and emperipolesis of intact lymphocytes within the cytoplasm of the lesional histiocytes (H&E, ×200).
Figure 3A

Histopathology report of case 2 shows a proliferation of histiocytes (arrow) and emperipolesis of intact lymphocytes within the cytoplasm of the lesional histiocytes (H&E, ×200).

Figure 3B Immunohistochemical staining against S-100, highlighting the emperipolesis in the histiocytes (×200) (arrow).
Figure 3B

Immunohistochemical staining against S-100, highlighting the emperipolesis in the histiocytes (×200) (arrow).

Figure 3C Immunohistochemical stains for CD1a show negativity in the lesional histiocytes.
Figure 3C

Immunohistochemical stains for CD1a show negativity in the lesional histiocytes.

2.3 Case 3

A 48 year-old woman was hospitalized and presented with purulent discharge in the left ear with left conductive hearing loss and persistent headache for 2 years. Neoplasm was found at the external auditory meatus by special examination and accessory MR examination (Figure 4). Under general anesthesia, the mass in the left external auditory meatus was removed, and auditory meatoplasty was conducted under microscopy. Histopathological and immunohistochemical findings were reported to support the diagnosis of extranodal RDD, with many of the histiocytes showing ingested lymphocytes, plasma cells, eosinophils, or neutrophils in the cytoplasm with staining positive for S100.

Figure 4A MR of case 3 demonstrates surrounding extension of the mass in the external auditory canal with irregular shape. The mass shows isointense on T1WI (white thin arrow).
Figure 4A

MR of case 3 demonstrates surrounding extension of the mass in the external auditory canal with irregular shape. The mass shows isointense on T1WI (white thin arrow).

Figure 4B The mass shows hypointense on T2WI (white thick arrow).
Figure 4B

The mass shows hypointense on T2WI (white thick arrow).

Figure 4C The mass with unclear boundary eroded into parotid gland and the temporal bone (black arrow).
Figure 4C

The mass with unclear boundary eroded into parotid gland and the temporal bone (black arrow).

Figure 4D The mass demonstrates obvious, homogeneous enhancement after the administration of intravenous contrast (long arrow).
Figure 4D

The mass demonstrates obvious, homogeneous enhancement after the administration of intravenous contrast (long arrow).

Though these three patients had different lesions, they all had a low fever and weight loss without any swollen lymph nodes around the whole body since onset. Their laboratory tests revealed normal results. And all of them had the same diagnosis: extranodal RDD. Oral prednisone was given to all of them with a 30 mg dose per day postoperatively for three months. The three cases all obtained curative effects, with relief of the above symptoms. There was no recurrence in the following 3 months (Figure 5), except case 1 was lost 2 months later.

Figure 5 No abnormal signal intensity is seen in the MR three months later for case 2 (thick arrow), except the hypointensity on T1WI and hyperintensity on T2WI due to secretory otitis media (thin arrow).
Figure 5

No abnormal signal intensity is seen in the MR three months later for case 2 (thick arrow), except the hypointensity on T1WI and hyperintensity on T2WI due to secretory otitis media (thin arrow).

Informed consent

Informed consent has been obtained from three individuals included in this study

Ethical approval

The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.

3 Discussion

Rosai-Dorfman Disease (RDD), originally described by Azoury and Reed, was reported and published as a rare distinct idiopathic histiocytic proliferative disorder by Rosai and Dorfman in 1969 [1]. It is characterized clinically by bilateral painless cervical lymphadenopathy (about 90%), while 43% of patients have extranodal involvement.

Isolated extranodal RDD without lymphadenopathy is less common. The most common sites of extranodal involvement are head and neck, in the skin and soft tissue. Other anatomic sites involving soft tissue in the back, arm, buttock, thigh, groin, as well as other tissues in the upper respiratory system, genitourinary tract, eye, orbit, kidney, thyroid, breast, bone, pancreatic tail, heart, and central nervous system have been reported [2, 5]. Here we report three rare cases diagnosed as isolated extranodal RDD, arising from the head and neck. One is in the maxillary, another is in the nasopharynx, and the third in the external auditory meatus.

The etiology of RDD has not been elucidated. Proposed mechanisms are summarized by three theories. One is related to a potential viral infection (including Epstein-Barr virus, parvovirus B19, and human herpes virus). Another is a disorder of immune regulation: stimulation of monocytes/macrophages via macrophage colony stimulating factor (M-CSF) leading to immune system suppression and production of numerous large histiocytes. The third is genetic mutation, which is confirmed by the existence of mutations in the gene SLC29A3 in familial RDD patients [3]. Sofia Garces found mutually exclusive KRAS and MAP2K1 mutations in one-third of cases of Rosai–Dorfman disease. She found a correlation with location (with disease manifestations being more common in the head and neck region), and a lack of correlation with disease outcome [4].

The hallmark of histopathological features of RDD is a proliferation of distinctive huge histiocytic cells that demonstrate emperipolesis (engulfment of different quantities of intact lymphocytes, plasma cells, and erythrocytes by the histiocytes) against a background of a mixed inflammatory infiltrate, consisting of abundant plasma cells and lymphocytes. The emperipolesis keeps the engulfed cell structure intact, distinct from phagocytosis of monocytes or macrocytes. In terms of immunohistochemistry, the RDD histiocytes present CD68 (+), S-100 (+), CD1a (-), which helps differentiate this condition from Langerhans cell histiocytosis showing S-100 (+), CD1a (+) [3] and rhinoscleroma with S-100 (-).

There are some specific features for extranodal RDD. 1. Increased fibrosis may obscure the histiocytes. 2. Lymph node structures and sinusoids are absent. 3. Blood vessels and lymph vessels are dilated and surrounded by the lymphocyte and plasma cell. 4. Fibrotic stromal reaction is more significant [5, 6]. The three extranodal RDD cases reported here were in accord with the above description.

The diagnosis of RDD depends on histopathological examination and immunohistochemistry.

The clinical typical features of RDD are bilateral painless enlarged cervical lymph nodes mimicking lymphoma, along with a low fever, night sweats, and weight loss. The presentation of extranodal RDD is related to the size and location of the mass and the organ damage, such as in the three cases here. The extent of damage depends on the dysfunction of the involved organs. Imaging ought to be performed with a concern for malignancy, focusing on the destruction of bone, with homogeneous postcontrast enhancement in all sites of involvement [7, 8]. A biopsy is advised. In the latest report, FDG PET-CT scanning is advised to evaluate the lesions, which display high radioglucose metabolism, and the staging, FDG-avidity is usually attributed to the infiltrative and inflammatory changes caused by the disease process. Ultimately, this imaging modality may aid in the drafting of therapeutic recommendations [9].

Pure cutaneous RDD (CRDD) has its own characteristics. Samir Dalia reported that the average age at onset of patients with CRDD is 45 years old. It predominately affects females and caucasians [10]. The size of lesions in CRDD can range from 1 cm to 30 cm or more at their widest. The presentation of papules or nodules is easily palpated, and discoloration or hyperpigmentation is always visible [7]. The most common site of skin involvement is the torso followed by the head and neck region [3]. Ultrasound is more useful for CRDD. Most cases were highly suspicious for malignancy (peripheral Doppler flow), but sometimes the ultrasound appearance of CRDD is atypical [7, 10].

RDD is a benign proliferative disorder, 20% of which is self-limited. In rare cases, RDD can be locally aggressive and involve the vital organs, causing death [10]. Furthermore, generalized lymphadenopathy and immune dysfunction both are poor prognosis factors for RDD patients [12]. Systemic treatment is pursued when patients have clinical symptoms or vital organ or system involvement. At present, due to its rarity and diversity, there are no particular guidelines regarding the management of RDD. Surgical intervention is the main management of treatment, especially for CRDD and RDD located in the central nervous system or larynx and airway and involving lymph nodes. Patients achieve long-term survival, and lesions from RDD stabilize, even though recurrence has occurred in the previous reported literature. Glucocorticoids are used in initial medical therapy for all kinds of RDD. The three cases here received oral prednisone for three months and obtained curative effects. However, the reliability and durability of these responses is unpredictable. Aradhana K et al [13] concluded that low dose radiation either in combination with surgery or corticosteroids in nodal or extranodal lesions has shown better local control through a five-year retrospective analysis. Chemotherapy may be managed for the patients with disseminated and multifocal RDD or for those whom both surgery and radiotherapy have failed [14, 15, 16, 17]. Arnao V et al [18] reported a case of an adult patient with isolated ocular and intracranial RDD, and mercaptopurine therapy stopped disease progression. They suggest that the use of purine antagonists and purine antimetabolites might be an efficacious treatment of adult forms of RDD. However, agreement is hampered by limited data.

More clinical trials and research are necessary before obtaining complete, scientific, and effective guidelines for RDD.

4 Conclusion

We summarize the etiology, pathology, diagnosis, clinical features, and treatment of RDD, aiming at increasing the knowledge of clinicians. Establishment of a standard of systemic treatment including surgery, steroids, radiotherapy, and chemotherapy is urgent for RDD patients.

  1. Conflict of interest: Authors state no conflict of interest.

References

[1] Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy: a newly recognized benign clinicopathological entity. Arch Pathol. 1969;87:63-70.Search in Google Scholar

[2] Warpe BM, More SV. Rosai-Dorfman disease: A rare clinicopathological presentation. Australas Med J. 2014;7(2):68-72.10.4066/AMJ.2014.1931Search in Google Scholar PubMed PubMed Central

[3] Dalia S, Sagatys E, Sokol L, Kubal T. Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment. Cancer Control. 2014;21(4):322-7.10.1177/107327481402100408Search in Google Scholar PubMed

[4] Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, et al. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol. 2017;30: 1367-77.10.1038/modpathol.2017.55Search in Google Scholar PubMed PubMed Central

[5] Xu J, Zhang L. Extranodal Rosai-Dorfman disease: a clinicopathological analysis of three cases. J Diag Pathol. 2013;20:596-9.Search in Google Scholar

[6] Chen YP, Jiang XN, Lu JP, Zhang H, Li XQ, Chen G. Clinicopathologic analysis of extranodal Rosai-Dorfman disease of breast: a report of 12 cases. Zhonghua Bing Li Xue Za Zhi. 2016;45(8):556-60.Search in Google Scholar

[7] Mantilla JG, Goldbergstein S, Wang Y. Extranodal Rosai-Dorfman Disease Clinicopathologic Series of 10 Patients with Radiologic Correlation and Review of the Literature. Am J Clin Pathol. 2016;145:211-21.10.1093/ajcp/aqv029Search in Google Scholar PubMed

[8] Xu Q, Fu L, Liu C. Multimodality imaging-based evaluation of Rosai–Dorfman disease in the head and neck: A retrospective observational study. Medicine. 2017; 96(51): e9372.10.1097/MD.0000000000009372Search in Google Scholar PubMed PubMed Central

[9] Hadchiti J, Kamar FG, Ghosn JA, Haidar M, Younes A, Obeid A, et al. 18F-fluoro-2-deoxyglucose positron emission-computed tomography in a rare cutaneous form of Rosai-Dorfman disease: A case report. Mol Clin Oncol. 2018;8(2): 236–41.10.3892/mco.2017.1507Search in Google Scholar PubMed PubMed Central

[10] Ciurea A, Ciortea C, Cosarca M, Cosarca M, Rogojan L. Breast Involvement in Pure Cutaneous Rosai-Dorfman Disease: Ultrasound and Sonoelastography appearance with a review of the literature. Ultrasound Quarterly. 2016;32:183-6.10.1097/RUQ.0000000000000170Search in Google Scholar PubMed

[11] O’Gallagher K, Dancy L, Sinha A, Sado D. Rosai-Dorfman disease and the heart. Intractable & Rare Diseases Research. 2016;5(1):1-5.10.5582/irdr.2015.01047Search in Google Scholar PubMed PubMed Central

[12] Sendrasoa FA, Ranaivo IM, Raharolahy O, Andrianarison M, Razanakoto NH, Ramarozatovo LS, et al. Rosai-Dorfman Disease Involving Multiple Organs: An Unusual Case with Poor Prognosis. Case Reports in Medicine. 2016;7:1-4.10.1155/2016/3920516Search in Google Scholar PubMed PubMed Central

[13] Aradhana K, Thejaswini B, Shamsundar A, Nanda R, Amritham U, Giri GV. Rosai-Dorfman Disease - Five Years Retrospective Analysis from Tertiary Cancer Center. Gulf J Oncolog. 2018;1(26):11-7.Search in Google Scholar

[14] Ramadass T, Thulasi P D, Geetha N, Narayanan N, Ayyaswamy G, Swapna S. Extranodal manifestation of Rosai Dorfman Disease of the nasopharynx. Indian J Otolaryngol Head Neck Surg. 2007;59(2):178-81.10.1007/s12070-007-0054-xSearch in Google Scholar PubMed PubMed Central

[15] Chen J, Tang H, Li B, Xiu Q. Rosai–Dorfman disease of multiple organs, including the epicardium: An unusual case with poor prognosis. Heart Lung. 2011;40(2):168-71.10.1016/j.hrtlng.2009.12.006Search in Google Scholar PubMed

[16] Paryani NN, Daugherty LC, O’Connor MI, Jiang L. Extranodal Rosai-Dorfman disease of the bone treated with surgery and radiotherapy. Rare Tumors. 2014;6(4):132-4.10.4081/rt.2014.5531Search in Google Scholar PubMed PubMed Central

[17] Niu Y, Li Y, Wang J, Jin X, Yang D, Huo H, Li W. Laryngeal Rosai-Dorfman Disease (Sinus Histiocytosis with Massive Lymphadenopathy): A Retrospective Study of 5 Cases. BioMed Research International. 2017; https://doi.org/10.1155/2017/8521818.10.1155/2017/8521818Search in Google Scholar PubMed PubMed Central

[18] Arnao V, Riolo M, Savettieri G, Aridon P. Mercaptopurine Treatment in an Adult Man with Orbital and Intracranial Rosai-Dorfman Disease. Case Rep Neurol Med. 2016; 10.1155/2016/1030478.Search in Google Scholar PubMed PubMed Central

Received: 2018-02-25
Accepted: 2018-05-08
Published Online: 2018-08-21

© 2018 Xue Zhao et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Research Article
  2. Purification of Tea saponins and Evaluation of its Effect on Alcohol Dehydrogenase Activity
  3. Runt-related transcription factor 3 promoter hypermethylation and gastric cancer risk: A meta-analysis
  4. Risk Factors for Venous Thromboembolism in Hospitalized Patients in the Chinese Population
  5. Value of Dual-energy Lung Perfusion Imaging Using a Dual-source CT System for the Pulmonary Embolism
  6. A new combination of substrates: biogas production and diversity of the methanogenic microorganisms
  7. mTOR modulates CD8+ T cell differentiation in mice with invasive pulmonary aspergillosis
  8. Direct Effects on Seed Germination of 17 Tree Species under Elevated Temperature and CO2 Conditions
  9. Role of water soluble vitamins in the reduction diet of an amateur sportsman
  10. Aberrant DNA methylation involved in obese women with systemic insulin resistance
  11. 16S ribosomal RNA-based gut microbiome composition analysis in infants with breast milk jaundice
  12. Characterization of Haemophilus parasuis Serovar 2 CL120103, a Moderately Virulent Strain in China
  13. MiRNA-145 induces apoptosis in a gallbladder carcinoma cell line by targeting DFF45
  14. Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
  15. Optimizing the Formulation for Ginkgolide B Solid Dispersion
  16. Determination of the In Vitro Gas Production and Potential Feed Value of Olive, Mulberry and Sour Orange Tree Leaves
  17. Factors Influencing the Successful Isolation and Expansion of Aging Human Mesenchymal Stem Cells
  18. The Value of Diffusion-Weighted Magnetic Resonance Imaging in Predicting the Efficacy of Radiation and Chemotherapy in Cervical Cancer
  19. Chemical profile and antioxidant activity of Trollius europaeus under the influence of feeding aphids
  20. SSR Markers Suitable for Marker Assisted Selection in Sunflower for Downy Mildew Resistance
  21. A Fibroblast Growth Factor Antagonist Peptide Inhibits Breast Cancer in BALB/c Mice
  22. Antihyperglycemic and antihyperlipidemic effects of low-molecular-weight carrageenan in rats
  23. Microbial indicators and environmental relationships in the Umhlangane River, Durban, South Africa
  24. TUFT1 promotes osteosarcoma cell proliferation and predicts poor prognosis in osteosarcoma patients
  25. Long non-coding RNA-2271 promotes osteogenic differentiation in human bone marrow stem cells
  26. The prediction of cardiac events in patients with acute ST segment elevation myocardial infarction: A meta–analysis of serum uric acid
  27. Risk expansion of Cr through amphibious clonal plant from polluted aquatic to terrestrial habitats
  28. Overexpression of Zinc Finger Transcription Factor ZAT6 Enhances Salt Tolerance
  29. Sini decoction intervention on atherosclerosis via PPARγ-LXRα-ABCA1 pathway in rabbits
  30. Soluble myeloid triggering receptor expressed on myeloid cell 1 might have more diagnostic value for bacterial ascites than C-reactive protein
  31. A Preliminary Study on the Newly Isolated High Laccase-producing Fungi: Screening, Strain Characteristics and Induction of Laccase Production
  32. Hydrolytic Enzyme Production by Thermophilic Bacteria Isolated from Saudi Hot Springs
  33. Analysis of physiological parameters of Desulfovibrio strains from individuals with colitis
  34. Emodin promotes apoptosis of human endometrial cancer through regulating the MAPK and PI3K/ AKT pathways
  35. Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer
  36. Inhibitory activities of ethanolic extracts of two macrofungi against eggs and miracidia of Fasciola spp.
  37. PAQR6 expression enhancement suggests a worse prognosis in prostate cancer patients
  38. Characterization of a potential ripening regulator, SlNAC3, from Solanum lycopersicum
  39. Expression of Angiopoietin and VEGF in cervical cancer and its clinical significance
  40. Umbilical Cord Tissue Derived Mesenchymal Stem Cells Can Differentiate into Skin Cells
  41. Isolation and Characterization of a Phage to Control Vancomycin Resistant Enterococcus faecium
  42. Glycogen Phosphorylase Isoenzyme Bb, Myoglobin and BNP in ANT-Induced Cardiotoxicity
  43. BAG2 overexpression correlates with growth and poor prognosis of esophageal squamous cell carcinoma
  44. Relationship between climate trends and grassland yield across contrasting European locations
  45. Review Articles
  46. Mechanisms of salt tolerance in halophytes: current understanding and recent advances
  47. Salivary protein roles in oral health and as predictors of caries risk
  48. Nanoparticles as carriers of proteins, peptides and other therapeutic molecules
  49. Survival mechanisms to selective pressures and implications
  50. Up-regulation of key glycolysis proteins in cancer development
  51. Communications
  52. In vitro plant regeneration of Zenia insignis Chun
  53. DNA barcoding of online herbal supplements: crowd-sourcing pharmacovigilance in high school
  54. Case Reports
  55. Management of myasthenia gravis during pregnancy: A report of eight cases
  56. Three Cases of Extranodal Rosai-Dorfman Disease and Literature Review
  57. Letters to the Editor
  58. First report of Chlamydia psittaci seroprevalence in black-headed gulls (Larus ridibundus) at Dianchi Lake, China
  59. Special Issue on Agricultural and Biological Sciences - Part II
  60. Chemical composition of essential oil in Mosla chinensis Maxim cv. Jiangxiangru and its inhibitory effect on Staphylococcus aureus biofilm formation
  61. Secondary metabolites of Antarctic fungi antagonistic to aquatic pathogenic bacteria
  62. Study of Seizure-Manifested Hartnup Disorder Case Induced by Novel Mutations in SLC6A19
  63. Transcriptome analysis of Pinus massoniana Lamb. microstrobili during sexual reversal
  64. Mechanism of oxymatrine-induced human esophageal cancer cell apoptosis by the endoplasmic reticulum stress pathway
  65. Methylation pattern polymorphism of cyp19a in Nile tilapia and hybrids
  66. A Method of Biomedical Information Classification based on Particle Swarm Optimization with Inertia Weight and Mutation
  67. A novel TNNI3 gene mutation (c.235C>T/ p.Arg79Cys) found in a thirty-eight-year-old women with hypertrophic cardiomyopathy
  68. Remote Sensing-Based Extraction and Analysis of Temporal and Spatial Variations of Winter Wheat Planting Areas in the Henan Province of China
  69. Topical Issue on Precision Medicine
  70. Serum sTREM-1, PCT, CRP, Lac as biomarkers for death risk within 28 days in patients with severe sepsis
  71. IL-17 gene rs3748067 C>T polymorphism and gastric cancer risk: A meta-analysis
  72. Efficacy of Danhong injection on serum concentration of TNF-α, IL-6 and NF-κB in rats with intracerebral hemorrhage
  73. An ensemble method to predict target genes and pathways in uveal melanoma
  74. Evaluation of the quality of CT images acquired with smart metal artifact reduction software
  75. NPM1A in plasma is a potential prognostic biomarker in acute myeloid leukemia
  76. Arterial infusion of rapamycin in the treatment of rabbit hepatocellular carcinoma to improve the effect of TACE
  77. New progress in understanding the cellular mechanisms of anti-arrhythmic drugs
Downloaded on 1.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2018-0032/html
Scroll to top button